# Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

> **NCT03945448** · PHASE2,PHASE3 · RECRUITING · sponsor: **Makerere University** · enrollment: 356 (estimated)

## Conditions studied

- Cryptococcal Meningitis

## Interventions

- **DRUG:** Single dose liposomal Amphotericin and Fluconazole
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT03945448
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-06-20
- **Primary completion:** 2027-06
- **Final completion:** 2027-08
- **Target enrollment:** 356 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945448, "Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03945448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*